Supreme Court: Award Valid Even If Passed After Mandate Expiry When Court Extends Time  ||  Jharkhand HC: Regular Bail Plea During Interim Bail is Not Maintainable under Section 483 BNSS  ||  Cal HC: Theft Claims and Public Humiliation Alone Don’t Amount To Abetment of Suicide U/S 306 IPC  ||  Delhi High Court: Elective Surgery Does Not Bar Grant of Interim Bail on Medical Grounds  ||  Delhi HC: Consensual Romance With Minor Nearing 18 May be Considered For Bail in POCSO Case  ||  Delhi HC: Not Named In FIR Doesn’t Matter If Financial Links Show Active Role in NDPS Offence  ||  Chhattisgarh HC: Rape is an Affront to Womanhood and a Brutal Violation of The Right To Life  ||  Supreme Court: Single Insolvency Petition Maintainable Against Linked Corporate Entities  ||  Supreme Court: Disputes are Not Arbitrable When the Arbitration Agreement is Alleged to be Forged  ||  Supreme Court: Temple Trust Does Not Qualify as an ‘Industry’ under the Industrial Disputes Act    

Search Results for Tag : trastuzumab

News

Delhi High Court to Roche: Can’t Hang on to Breast Cancer Drug For Lifetime(23.02.2017)

Delhi High Court has told Swiss pharma major Roche that it “cannot hang on to” breast cancer drug Trastuzumab, innovated by it, for rest of its life a.....

Tags : Delhi High Court, Trastuzumab, Breast Cancer



Delhi HC Restrains Reliance from Launching Copy of Roche's Breast Cancer Drug(05.11.2015)

Delhi High Court has restrained Reliance Life Sciences from launching a copy of Swiss Pharma Company Roche's breast cancer drug trastuzumab.

Tags : Delhi High Court , Reliance Life Sciences, breast cancer drug trastuzumab



Delhi HC Permits Sale and Manufacture of Breast Cancer Drug Trastuzumab(26.04.2016)

Delhi HC has allowed sale and manufacture of breast cancer drug trastuzumab by Biocon and Reliance Life Sciences, with certain restrictions.

Tags : Delhi HC, Breast Cancer Drug , Trastuzumab



Judgments

Delhi High Court to delve into Drug Controller irregularities(25.04.2016)

The Delhi High Court deferred a dispute regarding the development, classification and promotion of bio-similar drugs to 2 June 2016. Brought by Roche .....

Tags : trastuzumab, bio-similar, dcgi, roche



Disclaimer | Copyright 2026 - All Rights Reserved